American Association for Cancer Research
Browse
10780432ccr083087-sup-relatedarticle.html (0.75 kB)

Related Article from HER-2, Notch, and Breast Cancer Stem Cells: Targeting an Axis of Evil

Download (0.75 kB)
dataset
posted on 2023-03-31, 15:43 authored by Hasan Korkaya, Max S. Wicha
Related Article from HER-2, Notch, and Breast Cancer Stem Cells: Targeting an Axis of Evil

History

ARTICLE ABSTRACT

Increasing evidence indicates that tumor-initiating (cancer stem) cells may contribute to treatment resistance and relapse, suggesting that improved clinical outcome will require effective targeting of this cell population. Recent studies suggest that the remarkable clinical efficacy of trastuzumab may relate to its ability to target cancer stem cell populations.

Usage metrics

    Clinical Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC